Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Neladenoson dalanate (Neladenoson bialanate; BAY-1067197) is an orally active partial agonist precursor targeting the Adenosine A1 Receptor, demonstrating a favorable pharmacokinetic and safety profile. It is indicated for the management of chronic heart diseases.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,520.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | Neladenoson dalanate (Neladenoson bialanate; BAY-1067197) is an orally active partial agonist precursor targeting the Adenosine A1 Receptor, demonstrating a favorable pharmacokinetic and safety profile. It is indicated for the management of chronic heart diseases. |
Synonyms | Neladenoson bialanate ; BAY-1067197, BAY-1067197, Neladenoson bialanate |
Molecular Weight | 716.27 |
Formula | C35H34ClN7O4S2 |
CAS No. | 1239309-58-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Neladenoson dalanate 1239309-58-0 BAY1067197 Neladenoson bialanate ; BAY-1067197 BAY 1067197 Neladenoson bialanate ; BAY-1067197 F0401 Neladenoson bialanate ; BAY1067197 F-0401 BAY-1067197 Neladenoson bialanate ; BAY 1067197 Neladenoson bialanate inhibitor inhibit